FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
On Jul. 29, 2026, the U.S. Food and Drug Administration (FDA) announced it has licensed Ezplaz Freeze Dried…
-
-
Agriculture | Biotechnology | CDC | Diagnostics | Disease | FDA
Michigan reports 9,253 cyclosporiasis cases as infection outbreak expands
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
-
FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
U.S. FDA investigates another cyclosporiasis outbreak
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
-
FDA Approves Johnson & Johnson Market Authorization for OTTAVA™ Robotic Surgical System in the U.S.
On Jul. 22, 2026, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted…
-
FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
-
Agriculture | Biotechnology | Environmental | EPA | FDA | Forestry | Genomics | Implants | Infectious Disease | Marine Science | Medical Device | Oncology | Organ Transplant | Organoids | Pharmaceutical | Quantum | Robotics | Software | Stem Cell | U.S. Congress | Vaccine | Veterinary | Women's Health
New PhD Admissions Data Show Threat to U.S. STEM Workforce, Breakthroughs and Innovations
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
-
Biotechnology | Disease | FDA | Therapeutics
US FDA approves Vera’s kidney disease drug
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
-
Visby Medical Receives FDA Clearance for the First At-Home PCR for Multiple Respiratory Viruses
On Jul. 2, 2026, Visby Medical, the at-home diagnostics company, announced U.S. Food and Drug Administration (FDA) clearance…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
-
FDA to launch pilot program to speed up early-stage clinical trials
On Jun. 22, 2026, Federal health officials announced a pilot program Monday to speed up early-stage clinical trials,…
-
FDA panel backs first-of-its-kind flu vaccine using mRNA technology
On Jun. 18, 2026, a new kind of flu vaccine moved a step closer to the U.S. market…
-
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
-
FDA Issues EUA for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
On Jun. 11, 2026, The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for generic…
-
FDA Expands Sunscreen Options for the First Time in 20 Years
On Jun. 9, 2026, the U.S. Food and Drug Administration (FDA) announced it has added bemotrizinol to the…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
Measles cases mount in Florida, highest number reported in 25 years
On Jun. 2, 2026, The Florida Department of Health said there have been 154 measles cases in the…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
U.S. nears 2,000 measles cases as scientists note brain inflammation, pneumonia in hospital cases
On May 29, 2026, the U.S. Centers for Disease Control and Prevention (CDC) confirmed 31 new measles cases…
-
New kidney stone treatment powered by biomedical engineering research receives FDA approval
On May 25, 2026, Virginia Tech researchers announced they have received Food and Drug Administration (FDA) approval for…
-
Biotechnology | Diagnostics | FDA | Neurology
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
-
FDA Announces Major Steps to Implement Real-Time Clinical Trials
On Apr. 28, 2026, The U.S. Food and Drug Administration announced two major steps as part of an…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
U.S. Military Makes Flu Vaccine Optional
On Apr. 21, 2026, the annual influenza vaccines are no longer mandatory, said Pete Hegseth in a video…
-
FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
-
Biotechnology | Disease | FDA | Pharmaceutical | Rare Disease | Stem Cell
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves new higher-dose version of Wegovy shots
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
